Trupanion (NASDAQ:TRUP – Get Rating) had its price objective reduced by equities researchers at Piper Sandler from $150.00 to $95.00 in a research report issued to clients and investors on Friday, The Fly reports. Piper Sandler’s price objective suggests a potential upside of 37.70% from the company’s previous close.
Several other analysts also recently weighed in on the company. Lake Street Capital dropped their price objective on Trupanion from $150.00 to $120.00 in a research report on Thursday, February 17th. Bank of America dropped their price objective on Trupanion from $118.00 to $110.00 and set a “buy” rating for the company in a research report on Wednesday, April 20th. Zacks Investment Research upgraded Trupanion from a “hold” rating to a “buy” rating and set a $88.00 price objective for the company in a research report on Wednesday, April 20th. TheStreet downgraded Trupanion from a “c-” rating to a “d+” rating in a research report on Wednesday, April 6th. Finally, StockNews.com initiated coverage on Trupanion in a research report on Thursday, March 31st. They set a “sell” rating for the company. One equities research analyst has rated the stock with a sell rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of $110.60.
NASDAQ:TRUP opened at $68.99 on Friday. The stock has a fifty day moving average price of $83.78 and a 200-day moving average price of $102.37. The company has a market cap of $2.79 billion, a price-to-earnings ratio of -78.40 and a beta of 2.06. Trupanion has a fifty-two week low of $65.94 and a fifty-two week high of $158.25.
In related news, Director Michael Doak sold 700 shares of the business’s stock in a transaction on Tuesday, April 5th. The shares were sold at an average price of $97.26, for a total transaction of $68,082.00. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Darryl Rawlings sold 4,000 shares of the business’s stock in a transaction on Friday, February 4th. The shares were sold at an average price of $90.51, for a total transaction of $362,040.00. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 28,008 shares of company stock worth $2,422,408. Insiders own 6.77% of the company’s stock.
Institutional investors have recently added to or reduced their stakes in the stock. FNY Investment Advisers LLC acquired a new position in shares of Trupanion during the 4th quarter valued at $28,000. Rational Advisors LLC lifted its position in shares of Trupanion by 112.5% during the 4th quarter. Rational Advisors LLC now owns 238 shares of the financial services provider’s stock valued at $31,000 after acquiring an additional 126 shares during the period. Lindbrook Capital LLC acquired a new position in shares of Trupanion during the 4th quarter valued at $36,000. Harbor Investment Advisory LLC lifted its position in shares of Trupanion by 33.5% during the 1st quarter. Harbor Investment Advisory LLC now owns 714 shares of the financial services provider’s stock valued at $64,000 after acquiring an additional 179 shares during the period. Finally, Dark Forest Capital Management LP acquired a new position in shares of Trupanion during the 3rd quarter valued at $66,000. Institutional investors own 83.46% of the company’s stock.
About Trupanion (Get Rating)
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
- Get a free copy of the StockNews.com research report on Trupanion (TRUP)
- Apple’s Numbers Complete Trifecta
- Rogers Communication Stock Should Be Launching Higher
- O’Reilly Automotive Hits A Pothole
- Iridium Communications Stock is Ready to Return to Orbit
- There’s An Institutional Floor In Keurig Dr. Pepper
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.